Literature DB >> 7540330

Completion pneumonectomy: experience with 47 cases.

A Terzi1, G Furlan, A Terrini, G Magnanelli.   

Abstract

From 1982 through March 1994, fourty-seven patients underwent completion pneumonectomy for a reappearing lung cancer, lung metastases, late complications, benign lung diseases, and early complication of bronchial or pulmonary artery sleeve resections. Intraoperative bleeding was higher than in standard pneumonectomy; there was one intraoperative mortality (2.3%). Operative mortality was 14.9% overall but was 3.6% in completion pneumonectomy for lung cancer, 20% for late complications and benign disease, and 57% for the treatment of early complications of sleeve resections. Three and five-year survival in patients with lung cancer who survived the operation was 43.8% and 28.7% according to the Kaplan-Meier method; no significant difference in long-term survival was present between patients with a second primary lung cancer or recurrence. Completion pneumonectomy is indicated in reappearing lung cancer and should be considered in benign disease when a less invasive procedure is not available. Completion pneumonectomy for the treatment of early complications of bronchial or pulmonary artery sleeve resections has a very high mortality but no alternative is available.

Entities:  

Mesh:

Year:  1995        PMID: 7540330     DOI: 10.1055/s-2007-1013769

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  3 in total

1.  Completion pneumonectomy for recurrent or second primary lung cancer.

Authors:  M Muraoka; T Oka; T Takahashi; S Akamine; M Morinaga; T Nagayasu; Y Tagawa; H Ayabe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-07

2.  [Completion pneumonectomy. Indications and results].

Authors:  W Jungraithmayr; J Hasse; M Olschewski; E Stoelben
Journal:  Chirurg       Date:  2005-02       Impact factor: 0.955

3.  Completion pneumonectomy: Indications and outcomes in non-small cell lung cancer.

Authors:  Serkan Yazgan; Ahmet Üçvet; Soner Gürsoy; Özgür Samancılar
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-09-16       Impact factor: 0.332

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.